Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Burch, PA; Bernath, AM; Cascino, TL; Scheithauer, BW; Novotny, P; Nair, S; Buckner, JC; Pfeifle, DM; Kugler, JW; Tschetter, LK
   A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas
   INVESTIGATIONAL NEW DRUGS
   
   P.A. Burch et al., "A North Central Cancer Treatment Group phase II trial of topotecan in relapsed gliomas", INV NEW DR, 18(3), 2000, pp. 275-280
2. CREAGAN ET; VEEDER MH; SUMAN VJ; BURCH PA; MAPLES WJ; SCHAEFER PL; PFEIFLE DM; DALTON RJ; HATFIELD AK; POON MA
   A PHASE-II STUDY OF HIGH-DOSE CIMETIDINE AND THE COMBINATION 5-FLUOROURACIL, INTERFERON ALPHA-2A, AND LEUCOVORIN IN ADVANCED RENAL-CELL ADENOCARCINOMA
   American journal of clinical oncology
   
   E.T. Creagan et al., "A PHASE-II STUDY OF HIGH-DOSE CIMETIDINE AND THE COMBINATION 5-FLUOROURACIL, INTERFERON ALPHA-2A, AND LEUCOVORIN IN ADVANCED RENAL-CELL ADENOCARCINOMA", American journal of clinical oncology, 21(5), 1998, pp. 475-478
3. ELLIOTT TE; DINAPOLI RP; OFALLON JR; KROOK JE; EARLE JD; MORTON RF; LEVITT R; TSCHETTER LK; SCHEITHAUER BW; PFEIFLE DM; TWITO DI; NELIMARK RA
   RANDOMIZED TRIAL OF RADIATION-THERAPY (RT) PLUS DIBROMODULCITOL (DBD)VERSUS RT PLUS BCNU IN HIGH-GRADE ASTROCYTOMA
   Journal of neuro-oncology
   
   T.E. Elliott et al., "RANDOMIZED TRIAL OF RADIATION-THERAPY (RT) PLUS DIBROMODULCITOL (DBD)VERSUS RT PLUS BCNU IN HIGH-GRADE ASTROCYTOMA", Journal of neuro-oncology, 33(3), 1997, pp. 239-250
4. LONG HJ; LANGDON RM; CHA SS; VEEDER MH; PFEIFLE DM; KROOK JE; EBBERT LP; TSCHETTER LK; ROSHON SG
   PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT ENDOMETRIAL CARCINOMA
   Gynecologic oncology
   
   H.J. Long et al., "PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT ENDOMETRIAL CARCINOMA", Gynecologic oncology, 58(2), 1995, pp. 240-243
5. LOPRINZI CL; GOLDBERG RM; SU JQ; MAILLIARD JA; KUROSS SA; MAKSYMIUK AW; KUGLER JW; JETT JR; GHOSH C; PFEIFLE DM; WENDER DB; BURCH PA
   PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER
   Journal of clinical oncology
   
   C.L. Loprinzi et al., "PLACEBO-CONTROLLED TRIAL OF HYDRAZINE SULFATE IN PATIENTS WITH NEWLY-DIAGNOSED NON-SMALL-CELL LUNG-CANCER", Journal of clinical oncology, 12(6), 1994, pp. 1126-1129
6. DINAPOLI RP; BROWN LD; ARUSELL RM; EARLE JD; OFALLON JR; BUCKNER JC; SCHEITHAUER BW; KROOK JE; TSCHETTER LK; MAIER JA; PFEIFLE DM; GESME DH
   PHASE-III COMPARATIVE-EVALUATION OF PCNU AND CARMUSTINE COMBINED WITHRADIATION-THERAPY FOR HIGH-GRADE GLIOMA
   Journal of clinical oncology
   
   R.P. Dinapoli et al., "PHASE-III COMPARATIVE-EVALUATION OF PCNU AND CARMUSTINE COMBINED WITHRADIATION-THERAPY FOR HIGH-GRADE GLIOMA", Journal of clinical oncology, 11(7), 1993, pp. 1316-1321
7. GESME DH; JETT JR; SCHREFFLER DD; SU JQ; MAILLIARD JA; FOLEY JF; KROOK JE; MAKSYMIUK AW; HATFIELD AK; EBBERT LP; PFEIFLE DM; MORTON RF; TSCHETTER LK; SCHAEFER PL
   A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP
   Cancer
   
   D.H. Gesme et al., "A RANDOMIZED PHASE-II TRIAL OF AMONAFIDE OR TRIMETREXATE IN PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A TRIAL OF THE NORTH-CENTRAL-CANCER-TREATMENT-GROUP", Cancer, 71(9), 1993, pp. 2723-2726